Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Indolinone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Efficient asymmetric synthesis of chiral indolinone spiro compounds using cinchona alkaloid catalysts for high-purity pharmaceutical intermediates.
Patent CN115894563A reveals a green HPA-catalyzed route for isoindolinones. Discover cost reduction in pharmaceutical intermediates manufacturing and scalable supply solutions.
Patent CN105061290B reveals a novel Ce/Ag catalytic route for fluorinated indolinones. Achieve high yields and cost reduction in pharmaceutical intermediate manufacturing with scalable green chemistry.
Patent CN110483364A reveals metal-free photocatalytic route for indolinone sulfone. Enables cost reduction in pharmaceutical intermediates manufacturing with high purity.
Advanced synthesis of 3,3-disubstituted indolinones via copper-catalyzed radical cyclization. Cost-effective pharmaceutical intermediate manufacturing with scalable protocols.
Discover scalable synthesis routes for halogenated pyrrole substituted indolinones. Patent CN101440086B details multi-target kinase inhibitor intermediates with optimized manufacturing protocols.
Patent CN113584507B reveals a green continuous flow electrochemical method for sulfonylated isoindolinone, offering metal-free production and scalable supply chain solutions.
Advanced synthesis of substituted indolinones targeting CDK complexes. Offers streamlined routes for high-purity pharmaceutical intermediates and cost-effective API manufacturing.
Patent CN103421012A reveals a one-step synthesis for tricarbazole derivatives. This report analyzes cost reduction and supply chain advantages for high-purity OLED material manufacturing.
Novel micro-reactor electrochemical method for trifluoromethylated isoindolinones. Green, scalable process reducing metal waste and costs for pharma supply chains.
Novel method for chiral 3-fluoro-2-indolone derivatives via Ellman imine addition. High yield, mild conditions, scalable for API intermediates.
Patent CN103288708A reveals a mild, cost-effective route for 1-aryl-2-indolinone derivatives, offering significant supply chain advantages for API manufacturing.
Patent CN117946130A reveals a novel cinchona-catalyzed route for chiral spiro indolinone derivatives, offering significant cost reduction and supply chain reliability for anti-tumor drug manufacturing.
Novel one-step synthesis of anticancer spiroindolinone derivatives offers high purity and scalable production for pharmaceutical intermediate supply chains globally.
Patent CN108948034B reveals a novel tandem reaction for high-purity isoindolinone derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Green synthesis of isoindolinones using phenoxyacetonitrile. High yield, mild conditions. Cost-effective pharmaceutical intermediate manufacturing.
Patent CN112028816A reveals a novel route for bulky isoindoline derivatives, offering cost reduction in API manufacturing and enhanced supply chain reliability for complex heterocycles.
Patent CN113548999A details a novel Pd-catalyzed route to 3-(2,3-butadienyl)oxindoles with high enantioselectivity, offering cost-effective solutions for antiviral drug development.
Patent CN107573276A reveals NHC-catalyzed indolinone synthesis. High yield, mild conditions offer cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN109053543A reveals a base-catalyzed route for isoindole derivatives, offering cost reduction in pharmaceutical intermediate manufacturing and enhanced supply chain reliability.